The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient
- Conditions
- Liver Transplantation
- Registration Number
- NCT01457534
- Lead Sponsor
- Yonsei University
- Brief Summary
Background. Acute renal failure after liver transplantation (LT) requiring continuous renal replacement therapy (CRRT) adversely affects patient survival. However, there are few reports to assess the predictors for postoperative CRRT in liver transplant patients. The investigators undertook this study to identify perioperative factors that would predict patients at risk of CRRT.
Patients and Methods. The investigators retrospectively reviewed the data of 148 liver transplant patients from January 2007 to November 2010 at Severance Hospital, Yonsei University HealthSystem, in Seoul, Korea. The number of patients treated with CRRT was 44 (18 patients from living and 26 from deceased donors) and those without CRRT was 104. Univariate and stepwise logistic multivariate analyses were performed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 148
- Age 19-65 year
- Liver transplant patients from January 2008 to December 2011
- Patients treated with CRRT before transplantation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method status before operation 1 day before operation laboratory data(ex : total bilirubin, albumin, coagulation factors, blood gas analysis(arterial CO2 pressure. Blood urea nitrate/Creatinine, Hemoglobin/Hematocrit.)
the amount of ascites intraoperative the duration of anesthesia and operation intraoperative intraoperative hemodynamic instability intraoperative intraoperative bleeding intraoperative Intraoperative urine output intraoperative the types of donation(living or deceased donor) intraoperative survival rate on the postoperative 28th days, 365 days postoperative bleeding amount on the postoperative 28th days, 365 days. postoperative CRRT(continuous renal replacement therapy), on the postoperative 28th days, 365days mortality on the postoperative 28th days, 365 days.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Severance Hospital
🇰🇷Seoul, Korea, Republic of